XML 37 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2024
Current assets      
Cash and cash equivalents $ 73,001 $ 38,603  
Marketable securities (Notes 4 and 16) 89,638 80,854  
Trade and other receivables, no allowance for credit losses, as of March 31, 2025 and December 31, 2024 20,370 37,763  
Inventories (Note 6) 67,684 66,504  
Prepaid expenses and other current assets 6,187 6,463  
Total current assets 256,880 230,187  
Mineral properties, net (Note 7) 283,375 278,330  
Property, plant and equipment, net (Note 7) 57,031 55,187  
Investments (Note 8) 20,954 15,890  
Intellectual property, net (Note 3) 4,638 4,767  
Restricted cash (Note 9) 20,176 20,002  
Other assets 7,738 7,606  
Total assets 650,792 611,969  
Current liabilities      
Accounts payable and accrued liabilities (Note 14) 23,915 32,228  
Asset retirement obligations (Note 9) 15,925 24,604  
Contingent consideration (Notes 3 and 16) 1,725   $ 1,764
Other liabilities 707 693  
Total current liabilities 42,272 59,289  
Asset retirement obligations (Note 9) 21,616 19,513  
Other liabilities 1,475 1,490  
Total liabilities 65,363 80,292  
Equity      
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 214,837,845 and 198,666,994 as of March 31, 2025 and December 31, 2024, respectively 1,017,803 937,889  
Accumulated deficit (430,320) (404,023)  
Accumulated other comprehensive loss (6,669) (6,072)  
Total shareholders' equity 580,814 527,794  
Non-controlling interest 4,615 3,883  
Total equity 585,429 531,677 $ 387,690
Total liabilities and equity 650,792 611,969  
Commitments and contingencies (Note 14)